An observational study in Amblyopia, sponsored by Gobiquity Mobile Health. Completed at 1 site in United States. Open to participants aged 1 Year to 8 Years. Per ClinicalTrials.gov, last updated 2018-08-03.
Sponsored by Gobiquity Mobile Health · Observational
Among 82 studies in Amblyopia with a site in United States — 16 open to participants now, 17 under way, 3 of them phase 3. Amblyopia · United States.
Among the 82 studies in Amblyopia with a site in United States, this one is the 8th largest by enrollment of the 19 observational ones, is one of 4 that started in 2018, is one of 19 observational ones, and was the 50th registered.
189 studies on the registry are indexed under Amblyopia; 41 are open to participants now.
This study's enrollment of 207 is above the median of 156 across 39 observational studies indexed under Amblyopia.
Browse Amblyopia studies →16 of the 82 studies in Amblyopia with a site in United States are open now, in 1 country. Each count lists the studies.
Of the 30 Amblyopia studies recruiting now, 4 (13%) set no upper age limit and 24 (80%) stop at 75 or younger; 25 take children under 18; 7 take healthy volunteers.
This study: 1 Year to 8 Years · all sexes · no healthy volunteers.
The full table on the hub →82 studies; the count open now beside each. This study's row is marked.
First in 1999; this study’s year is marked. 4 started in 2018.
Median enrollment 53 across the 62 interventional studies, 156 across the 19 observational. Of the 56 that completed or were terminated, 19 (34%) have results posted.
12 of 82 have an industry lead sponsor. The 10 most frequent:
Gobiquity Mobile Health is the lead sponsor of 3 studies on the registry; none are open to participants now.
Gobiquity Mobile Health has 2 studies filed under Amblyopia — fewer than ten, so there is no comparison to draw.
7 of the studies in Amblyopia with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07554131University of OklahomaEvaluation of Echothiophate in Pediatric Patients With Refractory Amblyopia | 2026-12 |
| NCT03288948Retina Foundation of the SouthwestBinocular Amblyopia Treatment | 2026-12-31 |
| NCT06429280LuminopiaClinical Data Registry of Amblyopia Patients on Luminopia Treatment | 2026-12-31 |
| NCT05439200Retina Foundation of the SouthwestVideo Treatment for Amblyopia | 2027-01-31 |
| NCT05714449State University of New York College of OptometryOCT Eccentric Fixation and Amblyopia in Children | 2027-02-24 |
Among the 82 studies in Amblyopia with a site in United States, from their registry updates:
The objective is evaluation of GoCheck Kids, a smartphone application ('App'), for use as a photo screening device in a pediatric population to detect amblyopia risk factors (ARFs).
Detection of amblyopia risk factors using photo screening app in children of ages from 12 months to 8 years
Study population will be selected from eye clinics.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Device: App Vision Screening
Using GoCheck Kids App Vision Screening to detect Amblyopia Risk Factors
Sensitivity and specificity of amblyopia risk factors detected by Photorefraction
Identification of risk factors compared to gold standard cycloplegic refraction
Time frame: 1 day
Number of patients with gaze error identified by photo screening
Detection of gaze error compared to cover test examination results
Time frame: 1 day
Plan to share: Undecided
No publications or documents are linked to this record.
Ran from Feb 2018 to primary completion in Jun 2018, 3 months.
Of 16 observational studies under Amblyopia, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 22. This study's 3 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Aug 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.